Epidermal phospholipase Cδ1 regulates granulocyte counts and systemic interleukin-17 levels in mice

Nature Communications

Volumn 3, Issue , 2012, Pages

  Kanemaru, Kaori ^a   Nakamura, Yoshikazu ^a   Sato, Kojiro ^b   Kojima, Ryota ^a   Takahashi, Saori ^a   Yamaguchi, Mami ^a   Ichinohe, Manabu ^a   Kiyonari, Hiroshi ^c   Shioi, Go ^c   Kabashima, Kenji ^d   Nakahigashi, Kyoko ^d   Asagiri, Masataka ^d,e   Jamora, Colin ^f   Yamaguchi, Hideki ^g   Fukami, Kiyoko ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c RIKEN Center for Biosystems Dynamics Research   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SECTION OF CELL AND DEVELOPMENTAL BIOLOGY   (United States)

^g NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE; PHOSPHOLIPASE DELTA1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; PHOSPHOLIPASE C; WHN PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; GRANULOCYTE; GRANULOCYTOSIS; HUMAN; KERATINOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PSORIASIS; SKIN INFLAMMATION; ANIMAL; CELL STRAIN 3T3; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; EPIDERMIS; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE MUTANT;

3T3 CELLS; ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GRANULOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-17; KERATINOCYTES; MICE; MICE, KNOCKOUT; PSORIASIS; TYPE C PHOSPHOLIPASES;

EID: 84864863410     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms1960     Document Type: Article

References (58)

1. Berridge, M. J. & Irvine, R. F. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312, 315-321 (1984). (Pubitemid 15209307)
2. Nishizuka, Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 334, 661-665 (1988).
3. Suh, P. G. et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep. 41, 415-434 (2008).
4. Nakae, S. et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387 (2002). (Pubitemid 35279557)
5. Goverman, J. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9, 393-407 (2009).
6. Lubberts, E. et al. Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J. Immunol. 175, 3360-3368 (2005). (Pubitemid 41170558)
7. Nakae, S., Nambu, A., Sudo, K. & Iwakura, Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 171, 6173-6177 (2003). (Pubitemid 37467240)
8. Lee, E. et al. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J. Exp. Med. 199, 125-130 (2004). (Pubitemid 38076484)
9. Fujino, S. et al. Increased expression of interleukin 17 in inflammatory bowel disease. GUT 52, 65-70 (2003). (Pubitemid 36020767)
10. Yen, D. et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 116, 1310-1316 (2006).
11. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. & Gurney, A. L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278, 1910-1914 (2003). (Pubitemid 36801431)
12. Happel, K. I. et al. Roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170, 4432-4436 (2003). (Pubitemid 36519946)
13. Forlow, S. B. et al. Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice. Blood 98, 3309-3314 (2001).
14. Schwarzenberger, P. et al. IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J. Immunol. 161, 6383-6389 (1998). (Pubitemid 28536015)
15. Schwarzenberger, P. et al. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J. Immunol. 164, 4783-4789 (2000). (Pubitemid 30238080)
16. Fried, L. et al. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals. J. Am. Soc. Nephrol. 15, 3184-3191 (2004). (Pubitemid 39578851)
17. Margolis, K. L. et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch. Intern. Med. 165, 500-508 (2005). (Pubitemid 40344380)
18. Ruggiero, C. et al. White blood cell count and mortality in the Baltimore Longitudinal Study of Aging. J. Am. Coll. Cardiol. 49, 1841-1850 (2007). (Pubitemid 46661116)
19. Nakamura, Y. et al. Phospholipase C-d1 and-d3 are essential in the trophoblast for placental development. Mol. Cell. Biol. 25, 10979-10988 (2005). (Pubitemid 41747140)
20. Ichinohe, M. et al. Lack of phospholipase C-delta1 induces skin inflammation. Biochem. Biophys. Res. Commun. 356, 912-918 (2007). (Pubitemid 46541716)
21. Swamy, M., Jamora, C., Havran, W. & Hayday, A. Epithelial decision makers: in search of the 'epimmunome'. Nat. Immunol. 11, 656-665 (2010).
22. Nestle, F. O., Di Meglio, P., Qin, J. Z. & Nickoloff, B. J. Skin immune sentinels in health and disease. Nat. Rev. Immunol. 9, 679-691 (2009).
23. Xiao, W. et al. Tumor suppression by phospholipase C-β3 via SHP-1-mediated dephosphorylation of Stat5. Cancer Cell 16, 161-171 (2009).
24. Guo, Y., Rebecchi, M. & Scarlata, S. Phospholipase Cbeta2 binds to and inhibits phospholipase Cdelta1. J. Biol. Chem. 280, 1438-1447 (2005).
25. Ueda, Y., Kondo, M. & Kelsoe, G. Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow. J. Exp. Med. 201, 1771-1780 (2005). (Pubitemid 41002896)
26. Walkley, C. R. et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 129, 1097-1110 (2007). (Pubitemid 46908696)
27. Yang, L. et al. Cdc42 critically regulates the balance between myelopoiesis and erythropoiesis. Blood 110, 3853-3861 (2007). (Pubitemid 350248440)
28. Walkley, C. R., Yuan, Y. D., Chandraratna, R. A. & McArthur, G. A. Retinoic acid receptor antagonism in vivo expands the numbers of precursor cells during granulopoiesis. Leukemia 16, 1763-1772 (2002).
29. Nakamura, Y. et al. Phospholipase C-d1 is an essential molecule downstream of Foxn1, the gene responsible for the nude mutation, in normal hair development. FASEB J. 22, 841-849 (2008). (Pubitemid 351348136)
30. Lee, D., Prowse, D. M. & Brissette, J. L. Association between mouse nude gene expression and the initiation of epithelial terminal differentiation. Dev. Biol. 208, 362-374 (1999). (Pubitemid 29183996)
31. Oppmann, B. et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715-725 (2000).
32. Johansen, C. et al. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br. J. Dermatol. 160, 319-324 (2009).
33. Piskin, G., Sylva-Steenland, R. M., Bos, J. D. & Teunissen, M. B. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J. Immunol. 176, 1908-1915 (2006). (Pubitemid 43134336)
34. van der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 182, 5836-5845 (2009).
35. Homey, B. et al. Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J. Immunol. 164, 6621-6632 (2000). (Pubitemid 30408849)
36. Ong, P. Y. et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151-1160 (2002).
37. Wilson, N. J. et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8, 950-957 (2007). (Pubitemid 47300009)
38. Ettehadi, P. et al. Elevated tumour necrosis factor-Alpha (TNF-Alpha) biological activity in psoriatic skin lesions. Clin. Exp. Immunol. 96, 146-151 (1994). (Pubitemid 24213812)
39. Grossman, R. M. et al. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc. Natl Acad. Sci. USA 86, 6367-6371 (1989). (Pubitemid 19210653)
40. Broome, A. M., Ryan, D. & Eckert, R. L. S100 protein subcellular localization during epidermal differentiation and psoriasis. J. Histochem. Cytochem. 51, 675-685 (2003). (Pubitemid 36520623)
41. Sano, S. et al. Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat. Med. 11, 43-49 (2005). (Pubitemid 40215836)
42. Creamer, D., Allen, M. H., Sousa, A., Poston, R. & Barke, J. N. Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis. Br. J. Dermatol. 136, 859-865 (1997). (Pubitemid 27283516)
43. Hern, S., Stanton, A. W., Mellor, R., Levick, J. R. & Mortimer, P. S. Control of cutaneous blood vessels in psoriatic plaques. J. Invest. Dermatol. 113, 127-132 (1999). (Pubitemid 29328171)
44. Murphy, M., Kerr, P. & Grant-Kels, J. M. The histopathologic spectrum of psoriasis. Clin. Dermatol. 25, 524-528 (2007). (Pubitemid 350087598)
45. Micali, G., Lacarrubba, F., Musumeci, M. L., Massimino, D. & Nasca, M. R. Cutaneous vascular patterns in psoriasis. Int. J. Dermatol. 49, 249-56 (2010).
46. He, D. et al. IL-17 and IFN-? mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses. J. Immunol. 183, 21463-21470 (2009).
47. Larsen, J. M., Bonefeld, C. M., Poulsen, S. S., Geisler, C. & Skov, L. IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis. J. Allergy Clin. Immunol. 123, 486-492 (2009).
48. Cai, Y. et al. Pivotal role of dermal IL-17-producing d T cells in skin inflammation. Immunity, 4, 596-610 (2011).
49. Mabuchi, T., Takekoshi, T. & Hwang, S. T. Epidermal CCR6+ d T cells are major producers of IL-22 and IL-17 in a murine model of Psoriasiform dermatitis. J. Immunol. 187, 5026-5031 (2011).
50. Hedrick, M. N. et al. CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J. Clin. Invest. 119, 2317-2329 (2009).
51. Zheng, Y. et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 445, 648-651 (2007). (Pubitemid 46232884)
52. Leonardi, C. L. et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomized, double-blind, placebo-controlled trial (PHOENIX 1). The Lancet. 371, 1665-1674 (2008). (Pubitemid 351671883)
53. Shigeta, A. et al. An L-selectin ligand distinct from P-selectin glycoprotein ligand-1 is expressed on endothelial cells and promotes neutrophil rolling in inflammation. Blood 13, 4915-4923 (2008).
54. Meixner, A. et al. Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation. Nat. Cell Biol. 10, 1003-1011 (2008).
55. Nakamura, Y. et al. Phospholipase Cdelta1 is required for skin stem cell lineage commitment. EMBO J. 22, 2981-2991 (2003). (Pubitemid 36758619)
56. Dassule, H. R., Lewis, P., Bei, M., Maas, R. & McMahon, A. P. Sonic hedgehog regulates growth and morphogenesis of the tooth. Development. 127, 4775-4785 (2000).
57. Bleul, C.C. & Boehm, T. BMP signaling is required for normal thymus development. J. Immunol. 175, 5213-5221 (2005). (Pubitemid 41456406)
58. Kouchi, Z. et al. Phospholipase Cdelta3 regulates RhoA/Rho kinase signaling and neurite outgrowth. J. Biol. Chem. 286, 8459-8471 (2011).